Healthcare Economics & Policy

The investor-owned, Los Angeles-based provider announced Thursday, Nov. 7, that it’s teaming with to further spread AI tools across its 340 outpatient centers. 

If such technology is made available commercially, it could revolutionize magnetic resonance imaging, noted Stephan Anderson, a Boston Medical Center radiologist and BU School of Medicine professor of radiology. 

Clariscan is a gadolinium-based agent indicated for IV use in brain, spine and associated tissues to help detect areas with disruption of the blood brain barrier, or abnormal vascularity.

XACT said it planned to roll out the system at select U.S. radiology centers in the future, and will highlight its technology at RSNA’s annual meeting in Chicago later this year.  

Los Altos, California-based HeartVista has gained approval from the Food and Drug Administration for its one-click heart MRI examination tool. 

Radiologists' performance in the Merit-Based Incentive Payment System (MIPS) is best when MIPS-Alternative Payment Models replace group and individual reporting.

The American Society of Radiologic Technologists has announced 52 recipients of grants designed to support the professional and educational advancement of technologists and radiation therapists.

The vacancy rate for radiographers jumped from 4.2% in 2017 to 8.5% in 2019, according to a new survey published by the American Society of Radiologic Technologists.

“The impact of this groundbreaking solution for patients and healthcare providers is substantial," said President Brian Fleming. 

Radiology is evolving, consolidating and all the while innovating in this time of transition from volume to value across U.S. healthcare. A compressed field reflects the shape of the changed—and still changing—marketplace.

NYC Health + Hospitals announced Wednesday, Oct. 9, it plans to invest nearly a quarter of $1 billion to upgrade its imaging capabilities, hoping to standardize care across the vast enterprise.

Imaging giant GE Healthcare announced this week that it’s teaming with biotech firm Theragnostics in a bid to improve prostate cancer treatment.